The Cancer

Don't Miss

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...

How Most cancers Stole My Peace of Thoughts and Taught Me Resilience

Being robbed is simply part of life.Once I was in grammar college, little girls and boys would copy off my exams, stealing my solutions to...

FDA Clears PD-L1 Check to Information Keytruda Use in Ovarian Most cancers

The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...

Vital Information

Facts

Latest Articles

Addressing Challenges in TP53-Mutant Acute Myeloid Leukemia

Eunice S. Wang, MD, spoke with CancerNetwork® on the 2024 European Hematology Affiliation (EHA) Congress about ongoing challenges within the acute myeloid leukemia...

Prince William, Princess Kate’s staffing shake-up amid Kate’s most cancers remedy

Kate Middleton appeared together with her household at Trooping The Color this yr. Photograph / Getty PhotosPrincess Kate is constant to relaxation and...

Swim Throughout America occasion in Connecticut raises practically $500K for most cancers analysis

Swim Throughout America occasion in Connecticut raises practically $500K for most cancers analysis - CBS New York ...

Scientists develop unprecedented multiscale mannequin of protein conduct linked to cancer-causing mutations – Uncover LANL

Scientists develop unprecedented multiscale mannequin of protein conduct linked to cancer-causing mutations  Uncover LANL

Hot Topics